Startup Deep Dive : Plum Benefits — the broker that called a Rs 25.5 crore loss a good year

In the year to March 2024, Plum’s insurance business booked ₹41.3 crore in revenue and still lost ₹25.5 crore — and its founders treated that as a good year. It was: the loss was less than half the ₹55 crore Plum had burned a year earlier, and two years on, in March 2026, the company raised a fresh round at a reported valuation of about ₹1,181 crore while claiming it had crossed into EBITDA and cash-flow profitability.

Plum sells group health insurance and employee benefits to Indian startups and small companies — the kind of firms that historically found decent cover too expensive, too slow, or too opaque to buy. It is a broker with a software layer, not an insurer, and that distinction explains most of its economics. This deep dive traces how a two-founder company started in late 2019 went from covering a few hundred employers to a reported six-figure count of lives, what its filings actually show versus what its press releases claim, and why a business that earns a cut of someone else’s premium is harder to run profitably than it looks.

Quick facts

What they do

Plum sells group insurance and health benefits to employers, mostly startups and small-to-mid-sized companies, and gives their HR teams free software to run it. An employer signs up, Plum places a group health policy (and often group term life and personal accident cover) with an insurer, and employees get an app to check cover, add dependants, book teleconsultations and file claims. Plum is licensed by the insurance regulator as a direct broker, so it earns commission from insurers rather than charging the employer a separate fee for the core policy. Around this, it has layered health services — doctor consultations, health check-ups, mental wellness, dental and nutrition — that it now packages as “Plum Health”.

The origin

The founding insight was narrow and specific: group health insurance in India was built for large enterprises, and everyone smaller was an afterthought. Small companies paid more per head, waited weeks for quotes, and handed employees policies nobody could read. Abhishek Poddar had seen the machinery of consumer financial products up close — he spent 2013 to 2016 as a product manager at Google, where he worked on the launch of what became Google Pay, after an MBA at Stanford and an earlier stint as a business analyst at McKinsey following a mechanical-engineering degree from IIT Kanpur. Saurabh Arora came from the builder side: he had founded Airwoot, a social-customer-support platform later acquired by Freshworks, where he then served as a product head.

The two started Plum in late 2019 with a simple wedge — make buying and administering group health cover for a 20-person startup feel as easy as buying software. The bet was that if the onboarding and claims experience were good enough, small employers would switch, and that a broker sitting between many small firms and a few insurers could aggregate demand the incumbents ignored.

The struggle years

Two things made the early years hard, and both are visible in the record.

First, timing. Plum launched a product about workplace health months before COVID-19 emptied the workplaces. Selling group cover in 2020 meant selling to companies that were freezing hiring and cutting costs, even as the pandemic made health insurance suddenly urgent. Plum leaned into that urgency — adding telehealth and consultations early — but the customer base in late 2020 was still only around 200 companies.

Second, the economics of getting started. Broking is a thin-margin business that only works at scale, and Plum spent years buying that scale. Its filings show heavy losses well after launch: a net loss of ₹55 crore in FY23 on operating revenue of just ₹16.2 crore, meaning the company was spending several rupees for every rupee it earned. Employee costs alone ran far ahead of revenue as it hired to build the platform and sales engine. There was no single near-death drama in the public record; the struggle was the slower kind — a multi-year gap between a small commission base and a large cost base, funded by investors rather than customers, through a funding winter that hit Indian startups from 2022 onward.

The turning point

The turn shows up between FY23 and FY24. Revenue from operations went from ₹16.2 crore to ₹41.3 crore — about 2.5 times — driven almost entirely by insurance commission, which rose roughly 2.6 times to ₹38.46 crore and made up 93.08% of operating revenue. At the same time Plum cut total expenses from ₹81.1 crore to ₹70.8 crore, a rare combination of a business growing its top line while shrinking its cost base. The result: the net loss fell 54%, from ₹55 crore to ₹25.5 crore, in a single year.

That inflection — more commission, lower spend — is what let management start talking about profitability. By early 2025 Plum said it had been contribution-margin positive for close to a year and EBITDA-positive for a stretch of months, and by its March 2026 fundraise it described the prior period as its first with EBITDA and cash-flow profitability. The numbers on each side of the turn are the honest measure: a company that lost more than three rupees for every rupee of revenue in FY23 was, two years later, claiming it could stand on its own cash.

The money behind it

Plum has raised roughly $41 million across seed to Series B (reported, per Tracxn), from a tight group of repeat backers. The shape of the funding:

• Seed, July 2020: about ₹7 crore, led by Incubate Fund with Gemba Capital and Tracxn Labs and angels (Entrackr).
• Surge round, November 2020: ₹30 crore (about $4.1 million) led by Sequoia Capital India’s Surge with Tanglin Venture Partners; post-money valuation around ₹140 crore (Entrackr).
• Series A, May 2021: $15.6 million led by Tiger Global, with Sequoia’s Surge, Tanglin, Incubate Fund and Gemba Capital; a reported post-money valuation of about ₹630 crore ($87 million). Angel investors included Kunal Shah of CRED, the founders of Unacademy, Groww and Livspace (TechCrunch, Entrackr).
• Series B, March 2026: ₹193 crore ($20.6 million as reported) led by existing backer Peak XV Partners (the rebranded Sequoia India), with GMO Venture Partners and Tanglin; reported valuation about ₹1,181 crore (Inc42, YourStory, Life Insurance International).

What each backer changed is instructive. Surge and Sequoia/Peak XV provided the early conviction and the network of founder-angels that made Plum credible to the exact startups it wanted as customers. Tiger Global’s 2021 cheque funded the land-grab phase. Peak XV’s return in 2026 — leading again after profitability — signals a shift from growth-at-all-costs to funding a durable, cash-generating business and its move into healthcare services.

How it makes money

The model is broking, and the part people get wrong is that Plum does not carry insurance risk. It does not pay claims out of its own pocket; the insurer does. Plum’s economics look like this:

• Money in: commission from insurers on every group policy placed and renewed. In FY24 this commission was ₹38.46 crore, or 93.08% of operating revenue (RoC filing) — the business is, financially, almost entirely a commission engine.
• The renewal flywheel: group health policies renew annually, so each employer won becomes recurring commission if Plum keeps the account, which favours retention and service quality over one-off sales.
• Costs out: people, mostly. Employee-benefit expense was ₹54.3 crore in FY24, about 76.7% of total costs — this is a sales, servicing and engineering business, not an inventory or advertising one.
• Where margin sits: in scale and mix. Commission rates are regulated and broadly fixed, so the lever is volume and renewals against a largely fixed cost base — which is why revenue up 2.5x while costs fell was so consequential.
• The next layer: health services (Plum Health) and add-ons, which management wants to grow from a minority of revenue toward a much larger share, changing the mix beyond pure broking.

One caution on the numbers people quote: because Plum is a broker, its revenue is the commission it keeps, not the premium that flows through it. The premium handled is far larger than the ₹41.3 crore of FY24 revenue, and the two should never be conflated.

The numbers

Three years of reported figures for Plum’s insurance business, in ₹ crore. FY23 and FY24 are from RoC filings (via Entrackr); the FY25 revenue figure is company-stated around the March 2026 round and had not been confirmed in an audited filing at the time of writing.

The FY24 filing also showed an EBITDA margin of about -53.6% and a return on capital employed of about -39.2% — improving but still negative — alongside roughly ₹4 crore of other income, taking total income to about ₹45.3 crore. The trajectory is the story: losses more than halved in FY24, and the company reported revenue near ₹70 crore for FY25.

Where the money comes from

The revenue is concentrated by product and spread by customer, and the surprise is how one-note the income statement still is:

• By product: insurance commission was 93.08% of operating revenue in FY24 — Plum is, for now, overwhelmingly a broking business, with health services a small slice management wants to enlarge.
• By customer: startups and SMEs, with named clients spanning Zomato, Swiggy, Atlassian and CRED, and earlier adopters such as Twilio, Classplus and Happay. The base grew from about 200 companies in late 2020 to a reported 3,000 to 6,000 organisations by 2026 (sources differ), covering a reported figure of over 600,000 employees.
• The direction of travel: management has said its healthcare business was around 20% of corporate revenue and it wants that to reach roughly 40-45% within about two years (company-stated at the Series B), and that claims volumes had grown by around 50 times over four years.

The surprise for outsiders: a company marketed as a health-and-wellness platform still earns almost all its money from a single regulated commission line. Diversifying that mix is the explicit purpose of the 2026 raise.

The risks

• Commission concentration and regulation: with 93.08% of FY24 revenue from insurance commission, Plum’s income depends on a rate structure the IRDAI sets and can revise. Any tightening of broker commissions, or a change to how group health is priced, hits the core line directly. The broking licence also requires periodic renewal, an operating dependency rather than a given.
• Customer-base cyclicality: Plum’s buyers are startups and tech companies, and commission scales with covered headcount. Hiring freezes, layoffs and a funding winter shrink the number of insured employees per client, so a downturn in Plum’s own customer segment feeds straight into its revenue.
• Crowded field: Plum competes with other benefits-first insurtechs (such as Onsurity, Loop and Nova Benefits), with large aggregators moving into corporate cover, and with insurers’ own direct and enterprise channels. Commission being regulated, differentiation has to come from service and software, which are expensive to sustain.
• Profitability is recent and thin: the last confirmed filing (FY24) still showed a ₹25.5 crore loss and a negative EBITDA margin. Profitability is so far company-stated for a short, recent period, and the move into healthcare services could add cost before it adds durable margin.

The takeaway

The transferable lesson from Plum is about the discipline of a thin-margin, regulated business. For years it did the un-glamorous thing that broking demands — buy scale, build renewals, and wait for a largely fixed cost base to be covered by a growing commission base. The turn did not come from a clever new product; it came from revenue rising 2.5x in a year while costs actually fell, which is the only arithmetic that makes broking work. The instructive part is that Plum resisted diversifying its revenue until the core engine was near break-even, and only then used a profitable-company fundraise to push into healthcare services. For anyone building on someone else’s margin — a commission, a take rate, a fee — the message is that the model rewards patience and retention long before it rewards ambition.

Frequently asked questions

Is Plum an insurance company?

No. Plum is licensed as an insurance broker in India and places group policies with insurers; the insurer, not Plum, underwrites the cover and pays claims. Plum earns commission from the insurer, which was 93.08% of its operating revenue in FY24.

Who founded Plum and when?

Plum was founded in late 2019 in Bengaluru by Abhishek Poddar (CEO), previously a product manager at Google and a McKinsey analyst, and Saurabh Arora (CTO), who earlier founded Airwoot, later acquired by Freshworks.

How much money has Plum raised and at what valuation?

Plum has raised roughly $41 million to date (reported), including a $15.6 million Series A led by Tiger Global in 2021 and a ₹193 crore ($20.6 million) Series B led by Peak XV Partners in March 2026, at a reported valuation of about ₹1,181 crore.

Is Plum profitable?

Its last confirmed filing (FY24) showed a net loss of ₹25.5 crore, down 54% from ₹55 crore in FY23. Around its March 2026 round the company stated it had turned EBITDA and cash-flow positive, a claim not yet visible in an audited filing at the time of writing.

Is this the same as the beauty brand Plum?

No. The insurtech Plum described here is unrelated to Plum Goodness, the direct-to-consumer beauty brand. They share a name but are different companies with different owners and businesses; the financials here are only for the insurance business.

Sources

Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).

• Entrackr — Sequoia’s Surge leads ₹30 crore round in Plum Insurance (November 2020)
• TechCrunch — Indian health insurance startup Plum raises $15.6 million in Tiger Global-led investment (May 2021)
• Entrackr — Tiger Global leads $16 Mn round in Plum Insurance (May 2021)
• Entrackr / Fintrackr — Plum Insurance revenue surges 2.5X in FY24, cuts losses by half (December 2024)
• Inc42 — Insurtech startup Plum nets ₹193 Cr to expand employee health benefits platform (March 2026)
• YourStory — Plum Insurance raises ₹193 Cr in Series B round led by Peak XV Partners (March 2026)
• Life Insurance International — Indian insurtech company Plum secures $20m in Series B round (March 2026)
• Fintech Global — Plum raises Series B to scale claims experience in India (March 2026)
• YourStory — Plum invests ₹200 Cr to expand beyond insurance into preventive healthcare (July 2025)
• Tracxn — Plum company profile and funding (2026)
• The Company Check / Tracxn — Plum Benefits Insurance Brokers Private Limited legal-entity profile, CIN U66000KA2022PTC160458 (2026)
• plumhq.com — About Plum, mission and team (2026)
• IIT Kanpur, IndiaCSR and Wikipedia — Abhishek Poddar biography (2026)
• Inc42 and jeet.world — Saurabh Arora profile (2026)

Found an error? Write to us and we’ll correct it in the open, dated, on the piece.